The company uses a pioneering, non-invasive, bio-impedance technology of adapted multi-electrode measurements to detect osteoporotic changes in human bones. The corresponding electronic device is able to provide accurate data on bone mineral composition without exposing the patient to the harmful influence of ionizing radiation, allowing frequent measurements, therefore easy monitoring and early detection of osteoporotic changes. 

Thanks to its lightweight construction and battery operation the device becomes portable and allows for a broad population scan contributing to alleviating the cost to the public health system which are projected to reach $240 billion within the next 50 years in USA only.

BoneVitae S.A. Warszawa, Poland  www.bonevitae.com